비교리스트

 카트 문의
시장보고서
상품코드
1459806

세계의 소화관 출혈 치료 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Gastrointestinal Bleeding Treatment Market (Product: Endoscopic Hemostatic Devices, Closure Devices, and Others; and GI Tract Division: Upper GI Tract and Lower GI Tract) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 217 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

소화관 출혈 치료 시장 : 조사 범위

TMR사의 조사 보고서 「세계 소화관 출혈 치료 시장」은 2023년부터 2031년까지의 예측 기간에 있어서 시장 지표에 관한 귀중한 인사이트을 얻기 위해, 과거뿐만 아니라 현재의 성장 동향과 기회에 대해서도 조사 중입니다. 본 보고서는 2023년을 기준년, 2031년을 예측년으로, 2017년부터 2031년까지 세계 소화관 출혈 치료 시장의 수익과 예측을 제공합니다. 또한 2023년부터 2031년까지 세계 소화관 출혈 치료 시장의 복합 연간 성장률(CAGR)도 제공합니다.

이 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서 분석가는 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체와의 인터뷰를 실시했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서 등을 참조하여 소화관 출혈 치료 시장을 이해했습니다.

시장 현황
2022년 시장가치 5억 1,830만 달러
2031년 시장가치 8억 2,490만 달러
복합 연간 성장률(CAGR) 5.4%

이 보고서는 세계 소화관 출혈 치료 시장 경쟁 구도를 조사했습니다. 세계 소화관 출혈 치료 시장에서 사업을 전개하는 주요 기업이 확인되고, 이들 각 기업은 다양한 속성으로 프로파일링되고 있습니다. 기업 개요, 재무 상황, 최근 시장 개척, SWOT는 본 보고서에 소개된 세계 소화관 출혈 치료 시장에서 기업의 속성입니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약: 시장

제4장 시장 개요

  • 소개
  • 시장 개요
  • 시장 역학
  • 시장 분석과 예측(2017년-2031년)

제5장 주요 인사이트

  • 파이프라인 분석
  • 주요 제품/브랜드 분석
  • 주요 M&A
  • COVID-19 팬데믹의 산업에 대한 영향

제6장 시장 분석과 예측 : 제품별

  • 소개 및 정의
  • 주요 조사 결과/발전
  • 시장 매출 예측 : 제품별(2017년-2031년)
    • 내시경용 지혈 디바이스
      • 열 장치
      • 메카니컬 디바이스
    • 클로저 디바이스
    • 기타
  • 시장 매력도 분석 : 제품별

제7장 시장 분석과 예측 : 소화관 부분별

  • 소개 및 정의
  • 주요 조사 결과/발전
  • 시장 매출 예측 : 소화관 부분별(2017년-2031년)
    • 상부 소화관
    • 하부 소화관
  • 시장 매력도 분석 : 소화관 부분별

제8장 시장 분석과 예측 : 최종 사용자별

  • 소개 및 정의
  • 주요 조사 결과/발전
  • 시장 매출 예측 : 최종 사용자별(2017년-2031년)
    • 병원
    • 진료소
    • 외래수술센터(ASC)
    • 기타
  • 시장 매력도 분석 : 최종 사용자별

제9장 시장 분석과 예측 : 지역별

  • 주요 조사 결과
  • 시장 매출 예측 :지역별(2017년-2031년)
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장 매력도 분석 :지역별

제10장 북미 시장 분석과 예측

제11장 유럽 시장 분석과 예측

제12장 아시아태평양 시장 분석과 예측

제13장 라틴아메리카 시장 분석과 예측

제14장 중동 및 아프리카 시장 분석과 예측

제15장 경쟁 구도

  • 시장 경쟁 매트릭스(티어별, 기업 규모별)
  • 시장 점유율 분석 : 기업별(2022년)
  • 기업 프로파일
    • Boston Scientific Corporation
    • Olympus Corporation
    • CONMED Corporation
    • Cook Group
    • Ovesco Endoscopy AG
    • Erbe Elektromedizin GmbH
    • STERIS
    • US Medical Innovations
BJH 24.05.21

Gastrointestinal Bleeding Treatment Market - Scope of Report

TMR's report on the global gastrointestinal bleeding treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global gastrointestinal bleeding treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global gastrointestinal bleeding treatment market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the gastrointestinal bleeding treatment market.

Market Snapshot
Market Value in 2022US$ 518.3 Mn
Market Value in 2031US$ 824.9 Mn
CAGR5.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global gastrointestinal bleeding treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global gastrointestinal bleeding treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global gastrointestinal bleeding treatment market.

The report delves into the competitive landscape of the global gastrointestinal bleeding treatment market. Key players operating in the global gastrointestinal bleeding treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global gastrointestinal bleeding treatment market profiled in this report.

Key Questions Answered in Global gastrointestinal bleeding treatment Market Report:

  • What is the sales/revenue generated by gastrointestinal bleeding treatment across all regions during the forecast period?
  • What are the opportunities in the global gastrointestinal bleeding treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Gastrointestinal Bleeding Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global gastrointestinal bleeding treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global gastrointestinal bleeding treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global gastrointestinal bleeding treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Gastrointestinal Bleeding Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Endoscopic Hemostatic Devices
      • 6.3.1.1. Thermal Devices
      • 6.3.1.2. Mechanical Devices
    • 6.3.2. Closure Devices
    • 6.3.3. Others
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by GI Tract Division

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by GI Tract Division, 2017-2031
    • 7.3.1. Upper GI Tract
    • 7.3.2. Lower GI Tract
  • 7.4. Market Attractiveness Analysis, by GI Tract Division

8. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Clinics
    • 8.3.3. Ambulatory Surgical Centers
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Gastrointestinal Bleeding Treatment Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Product, 2017-2031
    • 10.3.1. Endoscopic Hemostatic Devices
      • 10.3.1.1. Thermal Devices
      • 10.3.1.2. Mechanical Devices
    • 10.3.2. Closure Devices
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by GI Tract Division, 2017-2031
    • 10.4.1. Upper GI Tract
    • 10.4.2. Lower GI Tract
  • 10.5. Market Value Forecast, by End-user, 2017-2031
    • 10.5.1. Hospitals
    • 10.5.2. Clinics
    • 10.5.3. Ambulatory Surgical Centers
    • 10.5.4. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Product
    • 10.7.2. By GI Tract Division
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Gastrointestinal Bleeding Treatment Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Product, 2017-2031
    • 11.3.1. Endoscopic Hemostatic Devices
      • 11.3.1.1. Thermal Devices
      • 11.3.1.2. Mechanical Devices
    • 11.3.2. Closure Devices
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by GI Tract Division, 2017-2031
    • 11.4.1. Upper GI Tract
    • 11.4.2. Lower GI Tract
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Clinics
    • 11.5.3. Ambulatory Surgical Centers
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By GI Tract Division
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Gastrointestinal Bleeding Treatment Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Product, 2017-2031
    • 12.3.1. Endoscopic Hemostatic Devices
      • 12.3.1.1. Thermal Devices
      • 12.3.1.2. Mechanical Devices
    • 12.3.2. Closure Devices
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by GI Tract Division, 2017-2031
    • 12.4.1. Upper GI Tract
    • 12.4.2. Lower GI Tract
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Clinics
    • 12.5.3. Ambulatory Surgical Centers
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product
    • 12.7.2. By GI Tract Division
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Gastrointestinal Bleeding Treatment Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Product, 2017-2031
    • 13.3.1. Endoscopic Hemostatic Devices
      • 13.3.1.1. Thermal Devices
      • 13.3.1.2. Mechanical Devices
    • 13.3.2. Closure Devices
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by GI Tract Division, 2017-2031
    • 13.4.1. Upper GI Tract
    • 13.4.2. Lower GI Tract
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Clinics
    • 13.5.3. Ambulatory Surgical Centers
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product
    • 13.7.2. By GI Tract Division
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Gastrointestinal Bleeding Treatment Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Product, 2017-2031
    • 14.3.1. Endoscopic Hemostatic Devices
      • 14.3.1.1. Thermal Devices
      • 14.3.1.2. Mechanical Devices
    • 14.3.2. Closure Devices
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by GI Tract Division, 2017-2031
    • 14.4.1. Upper GI Tract
    • 14.4.2. Lower GI Tract
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Clinics
    • 14.5.3. Ambulatory Surgical Centers
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By GI Tract Division
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Boston Scientific Corporation
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Olympus Corporation
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. CONMED Corporation
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Cook Group
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Ovesco Endoscopy AG
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Erbe Elektromedizin GmbH
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. STERIS
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. US Medical Innovations
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제